These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27027690)

  • 1. A recombinant C1 esterase inhibitor (Ruconest) for hereditary angioedema.
    Med Lett Drugs Ther; 2016 Mar; 58(1491):e44-5. PubMed ID: 27027690
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy.
    Moldovan D; Bernstein JA; Hakl R; Porebski G; Poarch K; Lumry WR; Relan A
    J Allergy Clin Immunol Pract; 2019; 7(8):2938-2940. PubMed ID: 31170541
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant replacement therapy for hereditary angioedema due to C1 inhibitor deficiency.
    Moldovan D; Bernstein JA; Cicardi M
    Immunotherapy; 2015; 7(7):739-52. PubMed ID: 26250409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
    Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
    J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma-derived C1-INH for managing hereditary angioedema in pediatric patients: A systematic review.
    Craig TJ; Schneider LC; MacGinnitie AJ
    Pediatr Allergy Immunol; 2015 Sep; 26(6):537-44. PubMed ID: 26111105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Management of Hereditary Angioedema Attacks.
    Katelaris CH
    Immunol Allergy Clin North Am; 2017 Aug; 37(3):541-556. PubMed ID: 28687108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary angioedema and pregnancy: a successful outcome using C1 esterase inhibitor concentrate.
    Gorman PJ
    Can Fam Physician; 2008 Mar; 54(3):365-6. PubMed ID: 18337530
    [No Abstract]   [Full Text] [Related]  

  • 8. Haegarda--a subcutaneous C1 esterase inhibitor for prevention of hereditary angioedema.
    Med Lett Drugs Ther; 2018 Feb; 60(1541):39-40. PubMed ID: 29485978
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.
    Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Relan A; Visscher S; Haase G; Kaufman L; Hack CE
    J Allergy Clin Immunol; 2010 Oct; 126(4):821-827.e14. PubMed ID: 20920772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant C1-inhibitor: effects on coagulation and fibrinolysis in patients with hereditary angioedema.
    Relan A; Bakhtiari K; van Amersfoort ES; Meijers JC; Hack CE
    BioDrugs; 2012 Feb; 26(1):43-52. PubMed ID: 22171564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.
    Riedl MA; Levy RJ; Suez D; Lockey RF; Baker JW; Relan A; Zuraw BL
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):295-9. PubMed ID: 23535096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful perinatal management of hereditary angioedema with normal C1 esterase inhibitor and factor XII mutation using C1 esterase inhibitor therapy.
    Gibbons KR; Abraham T; Sandhu M; Peppers BP; Girzhel JF; Hostoffer RW
    Ann Allergy Asthma Immunol; 2017 Dec; 119(6):558-559. PubMed ID: 29017903
    [No Abstract]   [Full Text] [Related]  

  • 13. Usefulness of C1 esterase inhibitor protein concentrate in the management of hereditary angioedema of oropharyngeal tissue.
    Yigit M; Sogut O; Lisar H; Yigit E
    Niger J Clin Pract; 2018 Apr; 21(4):531-533. PubMed ID: 29607870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency.
    Varga L; Farkas H
    Expert Rev Clin Immunol; 2011 Mar; 7(2):143-53. PubMed ID: 21426252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Conestat alpha: effective but not practical].
    Fain O
    Rev Prat; 2011 Nov; 61(9 Suppl):S5-6. PubMed ID: 22338198
    [No Abstract]   [Full Text] [Related]  

  • 16. Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients.
    Federici C; Perego F; Borsoi L; Crosta V; Zanichelli A; Gidaro A; Tarricone R; Cicardi M
    BMJ Open; 2018 Jul; 8(7):e022291. PubMed ID: 30061443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Use of Recombinant Human C1-INH in a Patient with Acquired Angioedema due to C1 Inhibitor Deficiency and an Unusually High Titer of Anti-C1-Inhibitor Autoantibodies.
    Jesenak M; Brndiarova M; Banovcin P; Varga L; Farkas H
    J Investig Allergol Clin Immunol; 2021 Jun; 31(3):255-256. PubMed ID: 32732186
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema.
    Riedl MA; Lumry WR; Li HH; Banerji A; Bernstein JA; Ba M; Bjrkander J; Magerl M; Maurer M; Rockich K; Chen H; Schranz J
    Allergy Asthma Proc; 2016 Nov; 37(6):489-500. PubMed ID: 27931305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-administration of intravenous C1 esterase inhibitor in hereditary angioedema.
    Rizk C; Karsh J; Santucci S; Yang W
    CMAJ; 2013 Jun; 185(9):791-2. PubMed ID: 23610020
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful C1 esterase inhibitor therapy in a child with a novel type 3 hereditary angioedema-like syndrome.
    Rasmussen JL; Park MA; Fischer PR
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):462-3. PubMed ID: 22626603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.